Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for Ischemic Lower Extremity Wounds
NCT06878482Phase 4Recruiting
- Sponsor
- Yonsei University
- Start
- Apr 2023
- Primary completion
- Mar 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in lower extremity ulcer, sponsored by Yonsei University. Started Apr 2023; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
lower extremity ulcer
Beyond the preview
Go deeper on NCT06878482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06878482.